Spelling suggestions: "subject:"biophysical"" "subject:"diophysical""
181 |
Chemical and biological studies on human oxygenasesThinnes, Cyrille Christophe January 2014 (has links)
As depicted in Chapter I, 2-oxoglutarate- (2OG) dependent oxygenases are ubiquitous in living systems and display a wide range of cellular functions, spanning metabolism, transcription, and translation. Although functionally diverse, the 2OG oxygenases share a high degree of structural similarities between their catalytic sites. From a medicinal chemistry point of view, the combination of biological diversity and structural similarity presents a rather challenging task for the development of selective small molecules for functional studies in vivo. The non-selective metal chelator 8-hydroxyquinoline (8HQ) was used as a template for the generation of tool compound <b>I</b> for the KDM4 subfamily of histone demethylases via application of the Betti reaction. Structural analogue <b>II</b> was used as the corresponding negative control (Figure A). These compounds were characterised in vitro against a range of 2OG oxygenases and subsequently used for studies in cells. <b>I</b> displays selectivity for KDM4 and increases the level of the H3K9me3 histone mark in cells. It has an effect on the post-translational modification pattern of histone H3, but not other histones, and reduces the viability of lung cancer cells, but not normal lung cells, derived from the same patient. <b>I</b> also stabilises hypoxia-inducable factor HIF in cells via a mechanism which seems to be independent from prolyl hydroxylase inhibition. This work is described in Chapters II and III. The chemical biology research in epigenetics is complemented by qualitative analysis conducted in the social sciences at Said Business School. With a global view on how innovation occurs and may actively be fostered, Chapter IV focuses on the potential of epigenetics in drug discovery and how this process may actively be promoted within the framework of open innovation. Areas of focus include considerations of incremental and disruptive technology; how to claim, demarcate, and control the market; how knowledge brokering occurs; and insights about process, management, organisation, and culture of open innovation. In contrast to the open-skies approach adopted for the development of a tool compound in Chapters II and III, a focused-library approach was taken for the generation of a tool compound for the OGFOD1 ribosomal prolyl hydroxylase. The development of a suitable in vitro activity assay for OGFOD1 in Chapter V enabled the development of lead compound <b>III</b> in Chapter VI. <b>III</b> is selective for OGFOD1 against the structurally closely related prolyl hydroxylase PHD2.
|
182 |
Advanced Electro-Quasistatic Human Body Communication and Powering: From Theory to Application for Internet of BodiesArunashish Datta (19207768) 07 August 2024 (has links)
<p dir="ltr">Decades of semiconductor technology scaling and breakthroughs in communication technology have miniaturized computing, embedding it everywhere, enabling the development of smart things connected to the internet, forming the Internet of Things. Further miniaturization of devices has led to an exponential increase in the number of devices in and around the body in the last decade, forming a subset of IoT which is increasingly becoming popular as the Internet of Bodies (IoB). The gradual shift from the current form of human-electronics coexistence to human-electronics cooperation, is the vision of Internet of Bodies (IoB). This vision of a connected future with devices in and around our body talking to each other to assist their day-to-day functions demands energy efficient means of communication. Electro-Quasistatic Human Body Communication (EQS-HBC) has been proposed as an exciting alternative to traditional Radio Frequency based methodologies for communicating data around the body. In this dissertation, we expand the boundaries of wearable and implantable IoB nodes using Electro-Quasistatic Human Body Communication and Powering by developing advanced channel models and demonstrating novel applications.</p><p dir="ltr">Leveraging the advanced channel models developed for wearable EQS-HBC, we demonstrate wearable applications like ToSCom which extend the use cases of touchscreens to beyond touch detection and location to enable high-speed communication strictly through touch. We further demonstrate an application of EQS Resonant Human Body Powering to demonstrate Step-to-Charge, allowing mW-scale wireless power transfer to wearable devices. With increasing connected implanted healthcare devices becoming a part of the IoB space, we benchmark RF-based technologies for In-Body to Out-of-Body (IBOB) communication using novel in-vivo experiments. We then explore EQS-HBC in the realm of IBOB communication using advanced channel modeling, revealing its potential for low-power and physically secure data transfer from implantable devices to wearable nodes on the body, demonstrating its potential in extending the battery life span of implantable nodes. Finally, an overview of the potential of IoB devices is analyzed with the use of EQS-HBC where we propose a human-inspired distributed network of IoB nodes which brings us a step closer to the potential for perpetually operable devices in and around the body.</p>
|
183 |
Structural Investigation of Processing α-Glucosidase I from Saccharomyces cerevisiaeBarker, Megan 20 August 2012 (has links)
N-glycosylation is the most common eukaryotic post-translational modification, impacting on protein stability, folding, and protein-protein interactions. More broadly, N-glycans play biological roles in reaction kinetics modulation, intracellular protein trafficking, and cell-cell communications.
The machinery responsible for the initial stages of N-glycan assembly and processing is found on the membrane of the endoplasmic reticulum. Following N-glycan transfer to a nascent glycoprotein, the enzyme Processing α-Glucosidase I (GluI) catalyzes the selective removal of the terminal glucose residue. GluI is a highly substrate-specific enzyme, requiring a minimum glucotriose for catalysis; this glycan is uniquely found in biology in this pathway. The structural basis of the high substrate selectivity and the details of the mechanism of hydrolysis of this reaction have not been characterized. Understanding the structural foundation of this unique relationship forms the major aim of this work.
To approach this goal, the S. cerevisiae homolog soluble protein, Cwht1p, was investigated. Cwht1p was expressed and purified in the methyltrophic yeast P. pastoris, improving protein yield to be sufficient for crystallization screens. From Cwht1p crystals, the structure was solved using mercury SAD phasing at a resolution of 2 Å, and two catalytic residues were proposed based upon structural similarity with characterized enzymes. Subsequently, computational methods using a glucotriose ligand were applied to predict the mode of substrate binding. From these results, a proposed model of substrate binding has been formulated, which may be conserved in eukaryotic GluI homologs.
|
184 |
Structural Investigation of Processing α-Glucosidase I from Saccharomyces cerevisiaeBarker, Megan 20 August 2012 (has links)
N-glycosylation is the most common eukaryotic post-translational modification, impacting on protein stability, folding, and protein-protein interactions. More broadly, N-glycans play biological roles in reaction kinetics modulation, intracellular protein trafficking, and cell-cell communications.
The machinery responsible for the initial stages of N-glycan assembly and processing is found on the membrane of the endoplasmic reticulum. Following N-glycan transfer to a nascent glycoprotein, the enzyme Processing α-Glucosidase I (GluI) catalyzes the selective removal of the terminal glucose residue. GluI is a highly substrate-specific enzyme, requiring a minimum glucotriose for catalysis; this glycan is uniquely found in biology in this pathway. The structural basis of the high substrate selectivity and the details of the mechanism of hydrolysis of this reaction have not been characterized. Understanding the structural foundation of this unique relationship forms the major aim of this work.
To approach this goal, the S. cerevisiae homolog soluble protein, Cwht1p, was investigated. Cwht1p was expressed and purified in the methyltrophic yeast P. pastoris, improving protein yield to be sufficient for crystallization screens. From Cwht1p crystals, the structure was solved using mercury SAD phasing at a resolution of 2 Å, and two catalytic residues were proposed based upon structural similarity with characterized enzymes. Subsequently, computational methods using a glucotriose ligand were applied to predict the mode of substrate binding. From these results, a proposed model of substrate binding has been formulated, which may be conserved in eukaryotic GluI homologs.
|
Page generated in 0.0522 seconds